United Orthopedic Corp

United Orthopedic Corp has a debt-to-equity ratio of 0.5, indicating a relatively conservative capital structure. The company's liquidity position is moderate, with a current ratio of 1.72, suggesting it can cover its short-term obligations but with limited excess cash. Free cash flow is negative at -36.89 million TWD, which may signal reinvestment in the business or operational constraints. Profitability metrics show a return on equity (ROE) of 13.72% and a return on assets (ROA) of 7.19%, both above the industry median for medical equipment firms. This suggests the company is effectively utilizing its equity and asset base to generate returns. Gross profit of 4.4 billion TWD represents a strong margin, but the operating income of 740.72 million TWD indicates some pressure from operating expenses. The company's revenue is distributed across multiple geographic regions, including Taiwan, the rest of Asia, the Americas, Europe, and Africa. However, the input data does not provide specific revenue concentration by region or product segment, so it is unclear whether the company is overexposed to any single market or product line. Looking ahead, the company's growth trajectory is not explicitly detailed in the input data. Analysts have provided a mean price target of 141.50 TWD, with a median of 141.50 TWD, and a strong consensus of four "buy" or "strong buy" recommendations. However, the absence of a detailed outlook for the current or next fiscal year limits the ability to assess near-term growth expectations. Risk factors include a negative net cash position after subtracting total debt, which could limit the company's flexibility in capital allocation or response to market shocks. The risk of dilution is assessed as low, and no specific dilution sources are identified in the input data. The company's capital expenditures of -761.23 million TWD suggest a significant investment in infrastructure or expansion. Recent events or filings are not detailed in the input data, so no specific recent developments can be cited. The company's financials and analyst estimates suggest a stable but not rapidly growing business, with a focus on maintaining profitability and managing debt.